On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Dárrel P. Francis

ResearcherPublications, citations & collaboration network

Dárrel P. Francis is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Dárrel P. Francis have?

ScholarIQindexed works

Dárrel P. Francis has 712 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Dárrel P. Francis have?

ScholarIQcitation count

Dárrel P. Francis has 35,513 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Dárrel P. Francis?

ScholarIQh-index

Dárrel P. Francis has an h-index of 94 in OpenAlex.

What is the i10-index of Dárrel P. Francis?

ScholarIQi10-index

Dárrel P. Francis has an i10-index of 358 in OpenAlex.

What is the ORCID of Dárrel P. Francis?

ScholarIQorcid

The ORCID for Dárrel P. Francis is on the source record.

What is the OpenAlex record for Dárrel P. Francis?

ScholarIQopenalex

The OpenAlex for Dárrel P. Francis is on the source record.

What are the most-cited papers on Dárrel P. Francis?

ScholarIQmost cited works
Uric Acid and Survival in Chronic Heart Failure
Stefan D. Anker, Wolfram Doehner, Mathias Rauchhaus, Rakesh Sharma, Dárrel P. Francis, Christoph Knosalla, Constantinos H. Davos, Mariantonietta Cicoira, Waqar Shamim, Michel Kemp, Robert Segal, Karl Josef Osterziel, Francisco Leyva, Roland Hetzer, Piotr Ponikowski, Andrew J.S. Coats
Circulation. 2003592 Citations
A Randomized Trial to Assess Catheter Ablation Versus Rate Control in the Management of Persistent Atrial Fibrillation in Heart Failure
David G. Jones, Shouvik Haldar, Wajid Hussain, Rakesh Sharma, Dárrel P. Francis, Shelley Rahman-Haley, Theresa A. McDonagh, S. Richard Underwood, Vias Markides, Tom Wong
Journal of the American College of Cardiology. 2013480 CitationsOPEN ACCESS
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
John G.F. Cleland, John R. Teerlink, Roxy Senior, Evgeny M. Nifontov, John Murray, Chim C. Lang, Vitaly A. Tsyrlin, Barry Greenberg, Jamil Mayet, Dárrel P. Francis, Tamaz Shaburishvili, Mark Monaghan, Mitchell Saltzberg, Ludwig Neyses, Scott M. Wasserman, Jacqueline H. Lee, Khalil G. Saikali, Cyril P. Clarke, Jonathan H. Goldman, Andrew A. Wolff, Fady I. Malik
The Lancet. 2011332 Citations

Related on ScholarIQ

470M+ articles · free account